newsfilter
← Latest News
PR Newswire·

Lipocine Announces Financial Results for the Third Quarter Ended September 30, 2025

Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics through effective...